Already live with teens, Cami turns Cambridge research into scalable, empathetic AI mental health care.
Business overview
| Location | London, United Kingdom |
|---|---|
| Social media | |
| Website | www.cambridgemindtechnologies.com/ |
| Sectors | SaaS/PaaS Digital B2B |
| Company number | 11691319 |
| Incorporation date | 22 Nov 2018 |
Investment summary
Business highlights
- Supporting real adolescent users now
- Cambridge spin-out with proven demand
- Trusted by schools & clinics - global rollout next
- Scaling safe, empathetic AI mental health care
Key features
Pitch
About the Campaign
Built on Cambridge research, Cami is already live with UK adolescents.
Your investment will help scale CMT globally, meeting rising demand for early, AI-powered mental health support for teens.
Backed by strong clinical demand and scalable tech, ready to expand across multiple global markets.
Market Opportunity
Most mental health apps attempt to replicate therapy.
Cami is different - it meets adolescents sooner.
Using Psychological First Aid, Cami safely de-escalates distress at scale, providing evidence-based early support before clinical care is needed.
Instant sub-clinical support at scale.
Traction & Key Accomplishments
Cami is live with adolescents via UK schools and clinics, with plans to scale to additional settings in the next few months.
Potential annual recurring revenue of £124,800 by end of 2025.
CMT has raised over £750k to date across two rounds, with all three major pre-seed investors following on at higher valuations (a 27% uplift), validating CMT’s progress and growth.
Adopted by clinicians, Cami reduces risk and extends care.
Developed from Cambridge research, CMT is revenue-ready and scaling globally.
Use of Funds
Funds will accelerate global rollout and commercial growth:
40% product development & AI
30% onboarding schools and clinics
20% research validation
10% operations
This round positions CMT for breakeven traction ahead of a 2026 seed expansion.
Key Information
Key information investment sheet
Key Investment Information Sheet is available by downloading the following documents:
- Key Investment Information Sheet [Danish]
- Key Investment Information Sheet [German]
- Key Investment Information Sheet [English]
- Key Investment Information Sheet [Spanish]
- Key Investment Information Sheet [French]
- Key Investment Information Sheet [Italian]
- Key Investment Information Sheet [Dutch]
- Key Investment Information Sheet [Portuguese]
- Key Investment Information Sheet [Swedish]
Part Time Team
The team at Cambridge Mind Technologies is currently part time.
Robert Batt, the Founder and CEO, commits 3.5 days/week to Cambridge Mind Technologies.
Robert Batt is also CEO at The Recovery Centre and TRC Group Midlands - who provide Adolescent Mental Health Clinics.
Following the completion of this round, Cambridge Mind Technologies will be employing at least 2 full-time team members.
Tax Relief
Investments up to £210,000 will receive SEIS relief.
Investments over this amount will receive EIS relief.
Open an account to get access to the team members of Cambridge Mind Technologies
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Only shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy sharesOnly shareholders can access this page
If you successfully purchase a share lot of this business, you will be granted access.
Buy shares
